Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Icon Plc
(NQ:
ICLR
)
214.25
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Icon Plc
< Previous
1
2
3
Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
November 15, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
November 15, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
November 14, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
ICON plc to Present at the Jefferies London Healthcare Conference
November 13, 2024
From
ICON plc
Via
Business Wire
ICON Reports Third Quarter 2024 Results
October 23, 2024
From
ICON plc
Via
Business Wire
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
September 27, 2024
From
ICON plc
Via
Business Wire
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
September 12, 2024
From
ICON plc
Via
Business Wire
ICON plc to Present at the Baird 2024 Global Healthcare Conference
September 03, 2024
From
ICON plc
Via
Business Wire
ICON Announces Appointment of New Chief Financial Officer
August 14, 2024
From
ICON plc
Via
Business Wire
ICON Reports Second Quarter 2024 Results
July 24, 2024
From
ICON plc
Via
Business Wire
ICON announces results of Annual General Meeting and changes to the Board of Directors
July 24, 2024
From
ICON plc
Via
Business Wire
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
July 10, 2024
From
ICON plc
Via
Business Wire
ICON plc Schedules Second Quarter 2024 Earnings Conference Call
July 01, 2024
From
ICON plc
Via
Business Wire
ICON plc to Present at the Jefferies Global Healthcare Conference
June 04, 2024
From
ICON plc
Via
Business Wire
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
May 30, 2024
From
ICON plc
Via
Business Wire
ICON plc to hold Investor Day Meeting on May 30, 2024
May 20, 2024
From
ICON plc
Via
Business Wire
ICON releases its ICON Cares 2023 Report
May 09, 2024
From
ICON plc
Via
Business Wire
ICON Announces Pricing of USD 2 Billion Notes
April 30, 2024
From
ICON plc
Via
Business Wire
ICON Reports First Quarter 2024 Results
April 24, 2024
From
ICON plc
Via
Business Wire
ICON Announces CFO Transition
April 03, 2024
From
ICON plc
Via
Business Wire
ICON plc Schedules First Quarter 2024 Earnings Conference Call
March 25, 2024
From
ICON plc
Via
Business Wire
ICON plc to Present at Upcoming Investor Conferences
February 26, 2024
From
ICON plc
Via
Business Wire
ICON Reports Fourth Quarter and Full Year 2023 Results
February 21, 2024
From
ICON plc
Via
Business Wire
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
January 30, 2024
From
ICON plc
Via
Business Wire
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
January 24, 2024
From
ICON plc
Via
Business Wire
ICON Issues Financial Guidance for Full Year 2024
January 09, 2024
From
ICON plc
Via
Business Wire
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
January 08, 2024
From
ICON plc
Via
Business Wire
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
ICON plc
Via
Business Wire
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
December 18, 2023
From
ICON plc
Via
Business Wire
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
December 07, 2023
From
ICON plc
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.